Pacific Biosciences of California, Inc. Restricted Cash, Noncurrent
Pacific Biosciences of California, Inc. (PACB) had Restricted Cash, Noncurrent of $1.53 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2024-11-12
- 2024-09-30: Restricted Cash, Noncurrent $1.53M.
- 2024-06-30: Restricted Cash, Noncurrent $1.92M.
- 2024-03-31: Restricted Cash, Noncurrent $2.42M.
- 2023-12-31: Restricted Cash, Noncurrent $2.42M.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2024-09-30 | $1.53M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.92M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $2.42M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.42M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $2.42M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $2.42M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $2.92M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.92M 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |